Last Price
3.55
Today's Change
-0.20 (5.33%)
Day's Change
3.47 - 3.79
Trading Volume
688,793
Overview
Market Cap
426 Million
Shares Outstanding
120 Million
Avg Volume
762,264
Avg Price (50 Days)
4.95
Avg Price (200 Days)
6.57
PE Ratio
-1.64
EPS
-2.17
Earnings Announcement
01-Nov-2024
Previous Close
3.75
Open
3.72
Day's Range
3.47 - 3.79
Year Range
3.47 - 13.273
Trading Volume
692,167
Price Change Highlight
1 Day Change
-5.33%
5 Day Change
-19.32%
1 Month Change
-19.32%
3 Month Change
-45.97%
6 Month Change
-56.39%
Ytd Change
-59.47%
1 Year Change
-71.20%
3 Year Change
-76.90%
5 Year Change
-76.90%
10 Year Change
-76.90%
Max Change
-76.90%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Apps
Top Articles
1
CEO Morning Brief
Ultra-rich Families Set to Control US$9.5 Tril by 2030, Says Deloitte
2
CEO Morning Brief
3
CEO Morning Brief
4
CEO Morning Brief
US Trade Deficit Widens to US$78.8 Bil, Largest in Two Years
5
CEO Morning Brief
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
